These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

284 related items for PubMed ID: 30924924

  • 21. Potential of [11C]UCB-J as a PET tracer for islets of Langerhans.
    Puuvuori E, Rokka J, Carlsson PO, Li Z, Eriksson J, Eriksson O.
    Sci Rep; 2021 Dec 28; 11(1):24466. PubMed ID: 34963683
    [Abstract] [Full Text] [Related]

  • 22. Use of brivaracetam in genetic generalized epilepsies and for acute, intravenous treatment of absence status epilepticus.
    Strzelczyk A, Kay L, Bauer S, Immisch I, Klein KM, Knake S, Kowski A, Kunz R, Kurlemann G, Langenbruch L, Möddel G, Müller-Schlüter K, Reif PS, Schubert-Bast S, Steinhoff BJ, Steinig I, Willems LM, von Podewils F, Rosenow F.
    Epilepsia; 2018 Aug 28; 59(8):1549-1556. PubMed ID: 29943451
    [Abstract] [Full Text] [Related]

  • 23. Efficacy and tolerability of adjunctive brivaracetam in patients with prior antiepileptic drug exposure: A post-hoc study.
    Asadi-Pooya AA, Sperling MR, Chung S, Klein P, Diaz A, Elmoufti S, Schiemann J, Whitesides J.
    Epilepsy Res; 2017 Mar 28; 131():70-75. PubMed ID: 28279891
    [Abstract] [Full Text] [Related]

  • 24. Development and In Vivo Preclinical Imaging of Fluorine-18-Labeled Synaptic Vesicle Protein 2A (SV2A) PET Tracers.
    Constantinescu CC, Tresse C, Zheng M, Gouasmat A, Carroll VM, Mistico L, Alagille D, Sandiego CM, Papin C, Marek K, Seibyl JP, Tamagnan GD, Barret O.
    Mol Imaging Biol; 2019 Jun 28; 21(3):509-518. PubMed ID: 30084043
    [Abstract] [Full Text] [Related]

  • 25. Brivaracetam efficacy and safety in focal epilepsy.
    Makke Y, Abou-Khalil B.
    Expert Rev Neurother; 2019 Oct 28; 19(10):955-964. PubMed ID: 31195850
    [Abstract] [Full Text] [Related]

  • 26. Kinetic evaluation and test-retest reproducibility of [11C]UCB-J, a novel radioligand for positron emission tomography imaging of synaptic vesicle glycoprotein 2A in humans.
    Finnema SJ, Nabulsi NB, Mercier J, Lin SF, Chen MK, Matuskey D, Gallezot JD, Henry S, Hannestad J, Huang Y, Carson RE.
    J Cereb Blood Flow Metab; 2018 Nov 28; 38(11):2041-2052. PubMed ID: 28792356
    [Abstract] [Full Text] [Related]

  • 27. Brivaracetam: review of its pharmacology and potential use as adjunctive therapy in patients with partial onset seizures.
    Mumoli L, Palleria C, Gasparini S, Citraro R, Labate A, Ferlazzo E, Gambardella A, De Sarro G, Russo E.
    Drug Des Devel Ther; 2015 Nov 28; 9():5719-25. PubMed ID: 26543353
    [Abstract] [Full Text] [Related]

  • 28. Assessing Synaptic Density in Alzheimer Disease With Synaptic Vesicle Glycoprotein 2A Positron Emission Tomographic Imaging.
    Chen MK, Mecca AP, Naganawa M, Finnema SJ, Toyonaga T, Lin SF, Najafzadeh S, Ropchan J, Lu Y, McDonald JW, Michalak HR, Nabulsi NB, Arnsten AFT, Huang Y, Carson RE, van Dyck CH.
    JAMA Neurol; 2018 Oct 01; 75(10):1215-1224. PubMed ID: 30014145
    [Abstract] [Full Text] [Related]

  • 29. Brivaracetam does not modulate ionotropic channels activated by glutamate, γ-aminobutyric acid, and glycine in hippocampal neurons.
    Niespodziany I, Rigo JM, Moonen G, Matagne A, Klitgaard H, Wolff C.
    Epilepsia; 2017 Nov 01; 58(11):e157-e161. PubMed ID: 28850675
    [Abstract] [Full Text] [Related]

  • 30. Adjunctive brivaracetam in focal and generalized epilepsies: A single-center open-label prospective study in patients with psychiatric comorbidities and intellectual disability.
    Foo EC, Geldard J, Peacey C, Wright E, Eltayeb K, Maguire M.
    Epilepsy Behav; 2019 Oct 01; 99():106505. PubMed ID: 31493736
    [Abstract] [Full Text] [Related]

  • 31. Clinical and Economic Outcomes of Intravenous Brivaracetam Compared With Levetiracetam for the Treatment of Seizures in United States Hospitals.
    Beaty S, Rosenthal NA, Gayle J, Dongre P, Ricchetti-Masterson K.
    Front Neurol; 2021 Oct 01; 12():760855. PubMed ID: 34912285
    [Abstract] [Full Text] [Related]

  • 32. Pharmacological Profile of the Novel Antiepileptic Drug Candidate Padsevonil: Interactions with Synaptic Vesicle 2 Proteins and the GABAA Receptor.
    Wood M, Daniels V, Provins L, Wolff C, Kaminski RM, Gillard M.
    J Pharmacol Exp Ther; 2020 Jan 01; 372(1):1-10. PubMed ID: 31619465
    [Abstract] [Full Text] [Related]

  • 33. Brivaracetam for the treatment of epilepsy.
    Schulze-Bonhage A.
    Expert Opin Pharmacother; 2011 Aug 01; 12(12):1959-66. PubMed ID: 21682662
    [Abstract] [Full Text] [Related]

  • 34. Reduced synaptic vesicle protein 2A binding in temporal lobe epilepsy: A [11 C]UCB-J positron emission tomography study.
    Finnema SJ, Toyonaga T, Detyniecki K, Chen MK, Dias M, Wang Q, Lin SF, Naganawa M, Gallezot JD, Lu Y, Nabulsi NB, Huang Y, Spencer DD, Carson RE.
    Epilepsia; 2020 Oct 01; 61(10):2183-2193. PubMed ID: 32944949
    [Abstract] [Full Text] [Related]

  • 35. First-in-Human Evaluation of 18F-SynVesT-1, a Radioligand for PET Imaging of Synaptic Vesicle Glycoprotein 2A.
    Naganawa M, Li S, Nabulsi N, Henry S, Zheng MQ, Pracitto R, Cai Z, Gao H, Kapinos M, Labaree D, Matuskey D, Huang Y, Carson RE.
    J Nucl Med; 2021 Apr 01; 62(4):561-567. PubMed ID: 32859701
    [Abstract] [Full Text] [Related]

  • 36. Safety and tolerability of adjunctive brivaracetam as intravenous infusion or bolus in patients with epilepsy.
    Klein P, Biton V, Dilley D, Barnes M, Schiemann J, Lu S.
    Epilepsia; 2016 Jul 01; 57(7):1130-8. PubMed ID: 27221208
    [Abstract] [Full Text] [Related]

  • 37. Pharmacokinetics and metabolism of 14C-brivaracetam, a novel SV2A ligand, in healthy subjects.
    Sargentini-Maier ML, Espié P, Coquette A, Stockis A.
    Drug Metab Dispos; 2008 Jan 01; 36(1):36-45. PubMed ID: 17908923
    [Abstract] [Full Text] [Related]

  • 38. Brivaracetam: a novel antiepileptic drug for focal-onset seizures.
    Stephen LJ, Brodie MJ.
    Ther Adv Neurol Disord; 2018 Jan 01; 11():1756285617742081. PubMed ID: 29399049
    [Abstract] [Full Text] [Related]

  • 39. Postmarketing experience with brivaracetam in the treatment of epilepsies: A multicenter cohort study from Germany.
    Steinig I, von Podewils F, Möddel G, Bauer S, Klein KM, Paule E, Reif PS, Willems LM, Zöllner JP, Kunz R, Runge U, Kurlemann G, Schubert-Bast S, Rosenow F, Strzelczyk A.
    Epilepsia; 2017 Jul 01; 58(7):1208-1216. PubMed ID: 28480518
    [Abstract] [Full Text] [Related]

  • 40. Association of synaptic density and cognitive performance in temporal lobe epilepsy: Humans and animals PET imaging study with [18F]SynVesT-1.
    Xiao L, Xiang S, Chen C, Zhu H, Zhou M, Tang Y, Feng L, Hu S.
    Psychiatry Clin Neurosci; 2024 Aug 01; 78(8):456-467. PubMed ID: 38804583
    [Abstract] [Full Text] [Related]

    Page: [Previous] [Next] [New Search]
    of 15.